Testing the diagnostic accuracy of a 68Ga-PSMA PET Scan in Early Biochemical Recurrence of Prostate Cancer
PET-PSMA is currently used for restaging prostate cancer (pCa) after primary surgery or radiotherapy. The PSA levels beyond which it is useful to perform it, in terms of cost-benefit ratio, are not to date clearly defined.
Shranjeno v:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Sciendo
2024-10-01
|
| Serija: | Forum of Clinical Oncology |
| Teme: | |
| Online dostop: | https://doi.org/10.2478/fco-2023-0034 |
| Oznake: |
Brez oznak, prvi označite!
|